Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding Short-Term Debt issuances Short-Term Debt repayments

TELA Bio (TELA) Shares Issued (2018 - 2026)

TELA Bio has reported Shares Issued over the past 8 years, most recently at $45000.0 for Q3 2025.

For Q3 2025, Shares Issued fell 27.42% year-over-year to $45000.0; the TTM value through Dec 2025 reached $105000.0, down 53.54%, while the annual FY2025 figure was $105000.0, 53.54% down from the prior year.
Shares Issued for Q3 2025 was $45000.0 at TELA Bio, down from $59000.0 in the prior quarter.
Over five years, Shares Issued peaked at $46.3 million in Q2 2022 and troughed at -$46.3 million in Q3 2023.
A 5-year average of $787937.5 and a median of $52000.0 in 2025 define the central range for Shares Issued.
On a YoY basis, Shares Issued climbed as much as 39813.79% in 2022 and fell as far as 25582.35% in 2022.
Year by year, Shares Issued stood at $136000.0 in 2021, then tumbled by 25582.35% to -$34.7 million in 2022, then surged by 99.96% to -$13000.0 in 2023, then surged by 576.92% to $62000.0 in 2024, then fell by 27.42% to $45000.0 in 2025.
Business Quant data shows Shares Issued for TELA at $45000.0 in Q3 2025, $59000.0 in Q2 2025, and $1000.0 in Q1 2025.